News
What Could AI Mean for Patient Recruitment? Matthew Stumm Joins Panel Discussion at CTSS Boston 2026

Boston is one of the most important cities in the world for clinical research. Nearly 400 active clinical trial sites. Global pharmaceutical leaders, emerging biotech companies, and world-renowned academic medical institutions operating within a few miles of each other. A concentration of clinical development expertise that is simply unmatched anywhere in the United States.
It is the right place to have the conversations that move this industry forward. And on April 30 and May 1, that is exactly what the Precision in Clinical Trials Summit Boston 2026 is designed to do.
Stark Raving Health will be exhibiting at PCT Boston 2026 — and we are looking forward to seeing you there.
The Precision in Clinical Trials Summit brings together 350+ senior leaders in clinical operations, clinical development, regulatory affairs, and vendor management for two days of high-level discussion, structured networking, and practical problem-solving. The attendees are the people making real decisions about how clinical trials are designed, staffed, and run — VPs, directors, heads of outsourcing, and C-suite leaders from pharma, biotech, and CROs.
The agenda tracks reflect where the industry's attention is right now: decentralized clinical trials, AI and machine learning, patient engagement and centricity, site selection and feasibility, data-driven trial design, and regulatory affairs. These are not abstract topics. They are the operational challenges the industry navigates every day — and they are directly connected to the patient recruitment and enrollment challenges that Stark Raving Health is built to solve.
Clinical trials can have exceptional protocols, talented investigators, and strong site networks — and still fall behind on enrollment. The patient recruitment challenge does not exist in isolation from the rest of clinical development. It is shaped by protocol design, site selection, regulatory requirements, decentralization strategy, and the way organizations think about patient engagement from the very beginning of a study.
That is the conversation we want to be having at PCT Boston. Not just how to run a recruitment campaign — but how patient recruitment strategy fits into the broader operational picture, where the biggest opportunities are being missed, and what it looks like when the whole system works together.
The sponsors and CROs attending this summit are grappling with these questions. We have spent years working alongside them — across therapeutic areas, geographies, and trial phases — and we have a perspective on what works, what doesn't, and where the field is heading that we are genuinely eager to share.
If you are attending the Precision in Clinical Trials Summit Boston, we would love to connect. Stop by the Stark Raving Health booth for a conversation about patient recruitment strategy, enrollment challenges, or anything else on your clinical development agenda. If you would prefer to schedule time in advance, reach out before the event and we will find a time that works.
Whether you are facing an enrollment deadline, evaluating recruitment partners, exploring decentralized recruitment strategies, or simply thinking through what your 2026 trial program needs — we are ready for the conversation.
The Precision in Clinical Trials Summit Boston 2026 runs April 30–May 1 at the Revere Hotel Boston Common.